Global healthcare company Abbott announced it had received authorisation from the health ministry’s Department of Medical Equipment and Construction to sell its Panbio COVID-19 Antigen Self-Test for the detection of the SARS-CoV-2 virus in Viet Nam
Over 2,250 adults will participate in a phase II/III trial for the new COVID-19 variant vaccine AstraZeneca’s AZD2816 to assess safety and immunogenicity against the SARS-CoV-2 virus, the company reported.
A test kit detecting SARS-CoV-2 virus researched and developed by a group of scientists from the Viet Nam Military Medical University received Bao Son Award 2020 which’s worth $60,000 in cash.
